Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ENRGISE: Losartan and Fish Oil for Inflammation and Mobility in Seniors
NCT02676466Phase 2Completed
- Sponsor
- University of Florida
- Start
- Apr 2016
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of losartan and omega-3-acid triglycerides in inflammation (8 arms), sponsored by University of Florida. Primary endpoints: Interleukin-6 at 12 months and Major Mobility Disability at 12 months. Started Apr 2016; status: completed.
02
Drugs
losartanomega-3-acid triglycerides
03
Conditions
inflammation
Beyond the preview
Go deeper on NCT02676466.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02676466.